PL445013A1 - Dieta ubogoarsenowa a ryzyko raków u kobiet - Google Patents

Dieta ubogoarsenowa a ryzyko raków u kobiet

Info

Publication number
PL445013A1
PL445013A1 PL445013A PL44501323A PL445013A1 PL 445013 A1 PL445013 A1 PL 445013A1 PL 445013 A PL445013 A PL 445013A PL 44501323 A PL44501323 A PL 44501323A PL 445013 A1 PL445013 A1 PL 445013A1
Authority
PL
Poland
Prior art keywords
cancer
arsenic
risk
women
diet
Prior art date
Application number
PL445013A
Other languages
English (en)
Inventor
Jan LUBIŃSKI
Cezary Cybulski
Tadeusz Dębniak
Jacek Gronwald
Tomasz Huzarski
Piotr Baszuk
Wojciech MARCINIAK
Róża Derkacz
Original Assignee
Read-Gene Spółka Akcyjna
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Read-Gene Spółka Akcyjna filed Critical Read-Gene Spółka Akcyjna
Priority to PL445013A priority Critical patent/PL445013A1/pl
Publication of PL445013A1 publication Critical patent/PL445013A1/pl

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/84—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Inorganic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Zgłoszenie opisuje sposób redukcji ryzyka raków u kobiet z dziedziczną predyspozycją do zachorowania na raka piersi, przy zastosowaniu diety ubogoarsenowej oraz zwiększenia redukcji ryzyka raków u w/w kobiet w zależności od stężenia selenu i arsenu we krwi.
PL445013A 2023-05-26 2023-05-26 Dieta ubogoarsenowa a ryzyko raków u kobiet PL445013A1 (pl)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL445013A PL445013A1 (pl) 2023-05-26 2023-05-26 Dieta ubogoarsenowa a ryzyko raków u kobiet

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL445013A PL445013A1 (pl) 2023-05-26 2023-05-26 Dieta ubogoarsenowa a ryzyko raków u kobiet

Publications (1)

Publication Number Publication Date
PL445013A1 true PL445013A1 (pl) 2024-12-02

Family

ID=93706878

Family Applications (1)

Application Number Title Priority Date Filing Date
PL445013A PL445013A1 (pl) 2023-05-26 2023-05-26 Dieta ubogoarsenowa a ryzyko raków u kobiet

Country Status (1)

Country Link
PL (1) PL445013A1 (pl)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL425602A1 (pl) * 2018-05-17 2019-01-02 Read-Gene Spółka Akcyjna Sposób określenia ryzyka raków u kobiet nie będących nosicielkami mutacji w genie BRCA1 i BRCA2 w zależności od stężeń we krwi arsenu, kadmu, cynku i/lub selenu

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL425602A1 (pl) * 2018-05-17 2019-01-02 Read-Gene Spółka Akcyjna Sposób określenia ryzyka raków u kobiet nie będących nosicielkami mutacji w genie BRCA1 i BRCA2 w zależności od stężeń we krwi arsenu, kadmu, cynku i/lub selenu

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MARCINIAK, W. ET AL.: "International Journal of Cancer: 146, 2721-2727 (2020)", " BLOOD ARSENIC LEVELS AND THE RISK OF FAMILIAL BREAST CANCER IN POLAND" *

Similar Documents

Publication Publication Date Title
Parva et al. Prevalence of vitamin D deficiency and associated risk factors in the US population (2011-2012)
Dalkin et al. Decreased incidence of prostate cancer with selenium supplementation: results of a double‐blind cancer prevention trial
BRPI0409919A (pt) combinações para o tratamento de doenças envolvendo proliferação, migração ou apoptose celular de células de células de mieloma, ou angiogênese
DE3473090D1 (en) Process for the simultaneous production of rapid short-channel and voltage-resistant mos transistors in vlsi circuits
JOP20230125A1 (ar) كانابيديول لعلاج النوبات المستعصية على العلاج
PL445013A1 (pl) Dieta ubogoarsenowa a ryzyko raków u kobiet
Doets et al. Explaining the variability in recommended intakes of folate, vitamin B12, iron and zinc for adults and elderly people
Wang et al. Associations of dietary oxidative balance score with femur osteoporosis in postmenopausal women: data from the National Health and Nutrition Examination Survey
Vivan et al. Prevalence of vitamin D depletion, and associated factors, among patients undergoing bariatric surgery in Southern Brazil
Grant et al. Vitamin D supplements and reasonable solar UVB should be recommended to prevent escalating incidence of chronic diseases
WO2021231475A3 (en) Systems and methods of promoting eubiosis in pregnant or breastfeeding women
BRPI0511187A (pt) método para tratar cáncer em um indivìduo
MX2025013867A (es) Metodos para tratar el cancer en sujetos con exposicion previa a inhibidores de punto de control inmunitario
Haider et al. The economic status of elderly divorced women
Roswall et al. Source-specific effects of micronutrients in lung cancer prevention
PL442921A1 (pl) Obniżanie ryzyka zgonów u kobiet z dziedziczną predyspozycją do raka piersi
Gülez et al. Factors influencing serum vitamin D concentration in Turkish children residing in İzmir: a single-center experience
Apriyanti et al. The Effect Of Giving Red Guava Juice To Grade of Pregnant Women’ s Hemoglobin
PL443075A1 (pl) Ryzyko zachorowania na raka u kobiet poniżej 50 roku życia z dziedziczną predyspozycją do raka piersi
Go The 2nd five-year masterplan for life-sustaining treatment: Key features and tasks
Eryılmaz et al. More sunlight exposure may improve the overall survival in patients with pancreas cancer
BRPI0608043A2 (pt) composição, método que promove a regressão do tumor, linhagem celular, método de identificação de um agente quimioterapêutico, método que promove a apoptose em células do tumor de mama, método de identificação de um agente que aumenta a apoptose em uma célula, uso de um agente e uso do ácido d-ala-l-glu-diaminopimélico
Decuypere et al. Male-to-female gender affirmation surgery: breast reconstruction with Ergonomix round prostheses
Chen et al. Association between Riboflavin Intake and Telomere length: a cross-sectional study from National Health and Nutrition Examination Survey 1999–2002
WO2005115472A3 (en) Compositions comprising gamma-linolenic acid and iodine for improving breast health in women